Clinical trials
Phase 2/3 COVID-19 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 10 |
| 2021 | 4 |
| 2022 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Abivax S.A. | 1 |
| Belfast Health and Social Care Trust | 1 |
| BioNTech SE | 1 |
| Gilead Sciences | 1 |
| Medicago | 1 |
| ModernaTX, Inc. | 1 |
| Novavax | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 18 |
| Coronavirus Infections | 3 |
| Glomerulonephritis | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Neoplasms | 1 |
| Vasculitis | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.